Cargando…
Pharmacologic Treatment with GABA(B) Receptor Agonist of Methamphetamine-Induced Cognitive Impairment in Mice
Methamphetamine (METH) is a highly addictive drug, and addiction to METH has increased to epidemic proportions worldwide. Chronic use of METH causes psychiatric symptoms, such as hallucinations and delusions, and long-term cognitive deficits, which are indistinguishable from paranoid schizophrenia....
Autores principales: | Mizoguchi, Hiroyuki, Yamada, Kiyofumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137162/ https://www.ncbi.nlm.nih.gov/pubmed/21886573 http://dx.doi.org/10.2174/157015911795016976 |
Ejemplares similares
-
Alzheimer’s Disease Animal Models: Elucidation of Biomarkers and Therapeutic Approaches for Cognitive Impairment
por: Nakai, Tsuyoshi, et al.
Publicado: (2021) -
PT688. PKCδ gene facilitates cognitive impairment induced by low doses of methamphetamine (MA) in mice
por: Tran, The-Vinh, et al.
Publicado: (2016) -
Mice carrying a schizophrenia-associated mutation of the Arhgap10 gene are vulnerable to the effects of methamphetamine treatment on cognitive function: association with morphological abnormalities in striatal neurons
por: Hada, Kazuhiro, et al.
Publicado: (2021) -
GABA(B)-Receptor Agonist-Based Immunotherapy for Type 1 Diabetes in NOD Mice
por: Tian, Jide, et al.
Publicado: (2021) -
Antitussive effects of the peripherally restricted GABA(B) receptor agonist lesogaberan in guinea pigs: comparison to baclofen and other GABA(B) receptor-selective agonists
por: Canning, Brendan J, et al.
Publicado: (2012)